SAB Biotherapeutics Inc. (SABS)

NASDAQ: SABS · Delayed Price · USD
5.25
-0.71 (-11.91%)
At close: Jan 26, 2022 4:00 PM
5.24
-0.01 (-0.25%)
After-hours:Jan 26, 2022 4:00 PM EST

Total Valuation

SABS has a market cap or net worth of $228.24 million. The enterprise value is $224.31 million.

Market Cap228.24M
Enterprise Value224.31M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

SABS has 43.47 million shares outstanding.

Shares Outstanding43.47M
Shares Change (YoY)n/a
Shares Change (QoQ)+138.07%
Owned by Insiders (%)42.46%
Owned by Institutions (%)28.24%
Float20.27M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
PB Ratio6.51
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Salesn/a
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.19.

Current Ratio2.09
Quick Ratio2.00
Debt / Equity0.19
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on Equity (ROE)n/a
Return on Assets (ROA)n/a
Return on Capital (ROIC)n/a
Revenue Per Employeen/a
Profits Per Employeen/a
Employee Count143
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

The stock price has decreased by -48.76% in the last 52 weeks.

Beta (1Y)n/a
52-Week Price Change-48.76%
50-Day Moving Average7.91
200-Day Moving Average9.33
Average Volume (30 Days)384,262

Short Selling Information

Short Interest398,689
Short % of Shares Out0.92%
Short % of Float1.97%
Short Ratio (days to cover)1.48

Income Statement

Revenuen/a
Gross Profitn/a
Operating Incomen/a
Net Incomen/a
EBITDAn/a
EBITn/a
Earnings Per Share (EPS)-$0.01
Full Income Statement

Balance Sheet

The company has $10.75 million in cash and $6.82 million in debt, giving a net cash position of $3.93 million or $0.09 per share.

Cash & Cash Equivalents10.75M
Total Debt6.82M
Net Cash3.93M
Net Cash Per Share$0.09
Book Value35.08M
Book Value Per Share0.81
Working Capital11.44M
Full Balance Sheet

Cash Flow

Operating Cash Flown/a
Capital Expendituresn/a
Free Cash Flown/a
FCF Per Sharen/a
Full Cash Flow Statement

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

SABS does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yieldn/a
FCF Yieldn/a
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a